Amedisys Inc (AMED)
Return on assets (ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -9,747 | 2,648 | 2,330 | 112,184 | 118,609 | 120,939 | 140,303 | 190,873 | 209,072 | 220,125 | 247,100 | 201,625 | 183,557 | 166,157 | 128,276 | 127,302 | 126,800 | 126,600 | 123,900 | 123,500 |
| Total assets | US$ in thousands | 2,060,170 | 2,027,420 | 1,982,400 | 1,946,960 | 1,976,240 | 1,982,130 | 2,000,990 | 1,908,390 | 1,856,970 | 1,937,640 | 1,599,560 | 1,573,210 | 1,567,200 | 1,602,720 | 1,645,490 | 1,440,080 | 1,262,740 | 1,212,380 | 1,205,860 | 1,184,240 |
| ROA | -0.47% | 0.13% | 0.12% | 5.76% | 6.00% | 6.10% | 7.01% | 10.00% | 11.26% | 11.36% | 15.45% | 12.82% | 11.71% | 10.37% | 7.80% | 8.84% | 10.04% | 10.44% | 10.27% | 10.43% |
December 31, 2023 calculation
ROA = Net income (ttm) ÷ Total assets
= $-9,747K ÷ $2,060,170K
= -0.47%
To analyze Amedisys Inc.'s return on assets (ROA) based on the provided data, we can observe significant fluctuations in ROA over the past eight quarters.
In Q1 2022, the ROA was 10.00%, indicating that the company generated $0.10 in net income for every dollar of assets it possessed. This high ROA suggests efficient asset utilization and profitability during that period.
However, the ROA sharply declined in subsequent quarters, reaching 7.01% in Q2 2022 and further dropping to 6.10% in Q3 2022. The downward trend continued in Q4 2022 with an ROA of 6.00%, representing lower profitability relative to the previous quarters.
The trend of decreasing ROA persisted into 2023, with Q1 2023 showing a considerable drop to 5.76%. This decline may raise concern about the company's ability to generate profits from its assets efficiently.
Subsequently, in Q2 and Q3 2023, the ROA remained relatively stable at 0.12% and 0.13%, respectively. However, in Q4 2023, there was a notable decrease as the ROA turned negative at -0.47%. A negative ROA implies that the company experienced a loss relative to its asset base during that period.
Overall, the fluctuating ROA over the analyzed quarters indicates varying levels of asset efficiency and profitability for Amedisys Inc. The negative ROA in Q4 2023 raises concerns about the company's financial performance and the need for further investigation into the factors affecting its profitability and asset utilization.
Peer comparison
Dec 31, 2023